MiR-32 antagonists to increase the response of prostate cancer to apoptosis

摘要

Use of an isolated miR-32 gene product comprising a miR antagonist to increase the response of prostate cancer cells to apoptotic stimuli, wherein the miR antagonist comprises an oligonucleotide sequence complementary to miR-32, or a precursor of the same.